ライフサイエンスコーパス: fluoroscopy

1 AR with and without MC and cone-beam CT with fluoroscopy).

2 nder local anesthesia, under x-ray guidance (fluoroscopy).

3 ad successful placement by the Team avoiding fluoroscopy.

4 rmation that cannot be obtained by 2D TEE or fluoroscopy.

5 andard nitinol guidewires during x-ray-based fluoroscopy.

6 t of the C6 vertebra on the right side under fluoroscopy.

7 ed fast field-echo) sequence was used for MR fluoroscopy.

8 solution manometry coupled with simultaneous fluoroscopy.

9 system (OAS) under simulated blood flow and fluoroscopy.

10 l digital detectors, to provide real time CT fluoroscopy.

11 CT were registered with projection images of fluoroscopy.

12 in the phantom at the time of CT imaging and fluoroscopy.

13 ocation was then determined by means of spot fluoroscopy.

14 nfarcted pigs, myocardium was targeted by MR fluoroscopy.

15 were injected intramyocardially under x-ray fluoroscopy.

16 went biopsy with computed tomography (CT) or fluoroscopy.

17 y intracardiac echocardiography and contrast fluoroscopy.

18 attempts, the feeding tube was placed under fluoroscopy.

19 ng of the knee was carefully standardized by fluoroscopy.

20 magnetic resonance (MR) angiography with MR fluoroscopy.

21 ar (LV) electromechanical maps without using fluoroscopy.

22 ed coronary calcium with digital subtraction fluoroscopy.

23 help of transesophageal echocardiography and fluoroscopy.

24 tissue interface not available with standard fluoroscopy.

25 r placement were ultrasound localization and fluoroscopy.

26 re and right radial artery pressure, and (5) fluoroscopy.

27 enient way to evaluate ureteral patency than fluoroscopy.

28 eaths and 4F-catheters were introduced under fluoroscopy.

29 he model in matched views to intraprocedural fluoroscopy.

30 etic assistance and under conventional x-ray fluoroscopy.

31 ardiography, video-assisted cardioscopy, and fluoroscopy.

32 ring percutaneous nephrolithotomy (PNL) from fluoroscopy.

33 e (20.5 Gy . cm(2) +/- 13.4 for cone-beam CT fluoroscopy, 12.6 Gy . cm(2) +/- 5.3 for AR, 13.6 Gy . c

34 vs. 1.49 +/- 0.026, P < 0.001) and need for fluoroscopy (2.1% vs. 10.9%, P < 0.001) significantly dr

35 e (10.4 Gy . cm(2) +/- 10.6 for cone-beam CT fluoroscopy, 2.3 Gy . cm(2) +/- 2.4 for AR, and 3.3 Gy .

36 9 [standard deviation] for cone-beam CT with fluoroscopy, 2.5 mm +/- 2.0 for AR, and 3.2 mm +/- 2.7 f

37 antly, but mean needle placement time for CT fluoroscopy (29 minutes; n = 95) was significantly lower

38 . 25.1%; p < 0.0001), calcified valves under fluoroscopy (32.4% vs. 18.8%, p < 0.0001) and with histo

39 ment of a radiopaque guidewire visible under fluoroscopy (6 dogs, 13 pigs).

40 ad preoperative upper gastrointestinal tract fluoroscopy (65.0%), these patients did not undergo a un

41 x-ray system operated at a low-frame pulsed fluoroscopy (7.5 frames per second).

42 edle aspiration or catheter drainages for CT fluoroscopy--98%, 86%, and 100%, respectively--were not

43 A near-zero fluoroscopy ablation could be performed in 14 of 44 proc

44 attempted in each of 10 dogs, half guided by fluoroscopy alone and half by ICE.

45 All injuries diagnosed with dynamic fluoroscopy and 101 (80.8%) of those diagnosed with MR i

46 ional approval was obtained to perform x-ray fluoroscopy and 90-minute left anterior descending coron

47 in the triangle of Koch directed by biplane fluoroscopy and a 6.2F, 12.5-MHz ICE catheter positioned

48 with a gap were created in the atrium using fluoroscopy and an electroanatomic system in the first g

49 SCV access site was directly measured using fluoroscopy and an intravascular guidewire.

50 an did lighter patients (<83 kg) during both fluoroscopy and cine; 44.9 mC/kg/min (173.9 R/min) vs. 2

51 Radiation oncologists performed fluoroscopy and cineangiography at most centers (92% and

52 ch is sufficient to be imaged under standard fluoroscopy and computed tomography (CT) imaging modalit

53 Fluoroscopy and computed tomography follow-up was perfor

54 days), but required substantial exposure to fluoroscopy and contrast.

55 rientation of the baskets were determined by fluoroscopy and echocardiography.

56 Postmortem studies, with advances such as fluoroscopy and electron microscopy, have also led to qu

57 electric conductivity, high visibility under fluoroscopy and excellent thermal-driven ability.

58 l space through this route, was confirmed by fluoroscopy and hemodynamic evidence.

59 e calculated total radiation exposure during fluoroscopy and image recording.

60 Both fluoroscopy and intracardiac ultrasound (ICE)-guided bal

61 Although there was a decrease in fluoroscopy and left atrium instrumentation time with th

62 , the left renal artery was cannulated under fluoroscopy and perfused at pressures of 100-150 mm Hg f

63 Fluoroscopy and procedure times were 31+/-21 (mean+/-SD)

64 aneous radiation reactions in interventional fluoroscopy and quantifying their clinical severity.

65 Fluoroscopy and radiofrequency current delivery times we

66 diac echocardiography (ICE, 10.5F, Siemens), fluoroscopy and saline flushing confirmed the absence of

67 (60%) of 10 injuries diagnosed with dynamic fluoroscopy and seven (5.6%) of 125 injuries diagnosed w

68 al artery and initially positioned by use of fluoroscopy and transesophageal echocardiography (TEE).

69 was measured during replay of the videotaped fluoroscopy and was correlated with manometric data.

70 procedures were performed with continuous CT fluoroscopy, and a combination technique was used for 25

71 diographic projections, computed tomography, fluoroscopy, and dental radiography.

72 General anesthesia, fluoroscopy, and echocardiographic guidance are used.

73 Calcification was defined by fluoroscopy, and its extent was graded from 1 to 4.

74 ects had their renal vein catheterized under fluoroscopy, and net renal glucose balance and renal glu

75 TEE, fluoroscopy, and pressure measurement were effective in

76 Procedural outcomes (procedure, fluoroscopy, and PVI times) were comparable between the

77 marked and significantly shorter procedure, fluoroscopy, and radiofrequency energy times.

78 ents were studied with concurrent manometry, fluoroscopy, and stepwise controlled barostat distention

79 ears, we observed a significant reduction in fluoroscopy- and acquisition-based air kerma rates in 20

80 A near-zero fluoroscopy approach can be achieved in up to half of th

81 Echocardiography and fluoroscopy are the main techniques for prosthetic heart

82 in the next decade likely will replace x-ray fluoroscopy as the primary diagnostic and interventional

83 uential transesophageal echocardiography and fluoroscopy as well as epicardial contrast echocardiogra

84 ligamentous injuries diagnosed with dynamic fluoroscopy, as reported in the literature, was 0.9% (11

85 l injections were performed entirely with MR fluoroscopy at 8 frames/s with 1.7x3.3x8-mm voxels.

86 pulmonary veins (PVs) are not delineated by fluoroscopy because there is no contrast differentiation

87 They overcome the limitations of fluoroscopy by creating accurate three-dimensional intra

88 This was repeated with conventional x-ray fluoroscopy by using clinical catheters and guidewires.

89 Intraoperative digital fluoroscopy can facilitate both placement verification a

90 efficacious than interlaminar ESIs, and that fluoroscopy can improve treatment outcomes, the evidence

91 arterialized hand vein and renal vein (under fluoroscopy) catheterized after an overnight fast.

92 d hand veins (artery) and renal veins (under fluoroscopy) catheterized after an overnight fast.

93 The Canadian Fluoroscopy Cohort Study includes 63,707 tuberculosis pa

94 92 knee OA patients, we obtained semiflexed, fluoroscopy-confirmed radiographs of the TF joint and we

95 int space width on radiographs of knees in a fluoroscopy-confirmed semiflexed position.

96 X-ray fluoroscopy constitutes the fundamental imaging modality

97 We describe a novel fluoroscopy coregistered, 4-dimensional catheter trackin

98 Fluoroscopy demonstrated securely positioned Melody valv

99 Biplane fluoroscopy determined catheter positions.

100 A region-of-interest (ROI) fluoroscopy device that provides an automatically genera

101 CT fluoroscopy documented inadequate positioning in 48 of t

102 Fluoroscopy duration was 16 +/- 3 min, 20 +/- 5 min, and

103 Mean fluoroscopy durations for AF procedures were 67.8+/-21 m

104 xposure in this study, despite the prolonged fluoroscopy durations, can be attributed to the use of v

105 gational accuracy compared with cone-beam CT fluoroscopy during image-guided percutaneous needle plac

106 visualize vascular calcification, including fluoroscopy, echocardiography, intravascular ultrasound,

107 Radiographic imaging methods, including fluoroscopy, electron-beam computed tomography, and heli

108 On average, PNL with fluoroscopy exposes patients to more radiation than a no

109 able clinical impact, MGT was able to reduce fluoroscopy exposure by nearly 50%.

110 ted safe and feasible ablation with very low fluoroscopy exposure even in patients with complex anoma

111 8.8 R/min) vs. 1.5 mC/kg/min (5.8 R/min) for fluoroscopy exposure rate.

112 agnification, and optimal adjustments of the fluoroscopy exposure rates.

113 Primary outcome measurements were CT fluoroscopy exposure time and patient dose.

114 There were significant differences in the fluoroscopy exposure time between diagnostic and interve

115 Median CT fluoroscopy exposure time was 12.6 seconds (range, 2.4-4

116 A near-zero fluoroscopy exposure was defined as those procedures wit

117 e of disease states with a minimal amount of fluoroscopy exposure.

118 ted into the distal femur metaphysis with MR fluoroscopy (fast imaging with steady-state precession,

119 ght to assess the effect of default rates of fluoroscopy (Fluoro) and CINE-acquisition (CINE) on tota

120 arteries of a VX2 tumor-bearing rabbit under fluoroscopy, followed by subsequent CT imaging.

121 This technique requires fluoroscopy for catheter manipulation, which in addition

122 hod is a satisfactory alternative to that of fluoroscopy for placement of long-term central venous ca

123 ented at the authors' institution, use of CT fluoroscopy for the guidance of interventional radiologi

124 is infused through a catheter directed under fluoroscopy from the mesenteric vein to the portal vein.

125 core-needle biopsy (CNB) under real-time CT fluoroscopy guidance.

126 , we proposed and validated the use of x-ray fluoroscopy-guidance in a rat model of RIPF to pinpoint

127 This optimizes intermittent-mode CT fluoroscopy-guided biopsies by allowing consistent visua

128 clinical trial compared intermittent mode CT fluoroscopy-guided biopsies of the lung or upper abdomen

129 ction of mobile target lesions throughout CT fluoroscopy-guided biopsy of the lung and upper abdomen.

130 intermittent-mode computed tomographic (CT) fluoroscopy-guided biopsy procedures in the lung or uppe

131 between physicians likely to have performed fluoroscopy-guided interventional (FGI) procedures (refe

132 o patients and personnel may occur during CT fluoroscopy-guided interventions.

133 provide superior radiation protection during fluoroscopy-guided interventions.

134 OCT pre- and post-PCI; OCT-guided group) to fluoroscopy-guided PCI (angiography-guided group).

135 This feasibility study showed that CT- and fluoroscopy-guided percutaneous facet screw fixation is

136 ocedural time was 46 minutes longer than the fluoroscopy-guided PTA procedural time; this difference

137 ference between MR imaging- and conventional fluoroscopy-guided renal artery PTA in terms of success

138 The authors performed fluoroscopy-guided sacroiliac (SI) joint injections.

139 e contralateral artery by using conventional fluoroscopy-guided techniques.

140 ined for this HIPAA-compliant study, and 144 fluoroscopy-guided vascular interventions were included

141 Two hundred twenty CT fluoroscopy--guided interventional procedures were perfo

142 MR fluoroscopy has the potential to guide intramyocardial M

143 The limitations of standard fluoroscopy have led to the development of improved imag

144 Compared with fluoroscopy, ICE guidance improved targeting, energy del

145 ed from 42 patients using procedural biplane fluoroscopy images, after balloon inflation, at systole

146 verlapping beads seen both in the CT and the fluoroscopy images.

147 atform under epicardial echocardiography and fluoroscopy imaging.

148 ophageal echocardiography (TEE) and contrast fluoroscopy immediately, then with TEE at 1 day, 30 days

149 al electrogram amplitude was estimated using fluoroscopy in 3 patients and a magnetic mapping system

150 superiority of either MR imaging or dynamic fluoroscopy in the diagnosis of unstable ligamentous inj

151 mapping caused a silent switch to continuous fluoroscopy in two such units, which doubled the exposur

152 early displayed, demonstrating that arterial fluoroscopy in which an MR technique is used is feasible

153 tion can be challenging, time consuming, and fluoroscopy intense.

154 Although CT fluoroscopy is a useful targeting technique, significant

155 Spatial resolution for fluoroscopy is adequate for most of the facilities surve

156 Knowledge of echocardiography and fluoroscopy is beneficial.

157 Fluoroscopy is essential for guiding the radiologist to

158 minimal tissue discriminative capability of fluoroscopy is mitigated in part by the use of electroan

159 Screening with fluoroscopy is reasonable.

160 Fluoroscopy is still important, but great advances in te

161 rograms, surface electrocardiograms, frontal fluoroscopy, lateral roentgenograms, and pacing threshol

162 nsertion has been established which includes fluoroscopy, lateral roentgenograms, intracardiac and su

163 complete the isthmus block with conventional fluoroscopy (median, three lesions; interquartile range,

164 uoroscopy (n=196) and single-image spiral CT fluoroscopy (n=175).

165 multi-detector row computed tomographic (CT) fluoroscopy (n=196) and single-image spiral CT fluorosco

166 beam computed tomography (CT) with real-time fluoroscopy navigation in a pig model.

167 mographics, anatomical information, detailed fluoroscopy need, procedure time, and adverse events wer

168 If the cost of fluoroscopy or the IR suite exceeds $100, strategy A is

169 in at the patient's bedside, (b) the cost of fluoroscopy or the IR suite, and (c) the intended use of

170 MR fluoroscopy permits visualization of catheter navigation

171 Infarct-enhanced MR fluoroscopy permitted excellent delineation of infarct b

172 ween measured and computed skin exposures in fluoroscopy, plain radiography, and digital imaging was

173 eal-time magnetic resonance imaging or x-ray fluoroscopy plus C-arm computed tomographic guidance.

174 uoroscopic spot images, personnel performing fluoroscopy, practice settings, and degree of specializa

175 opists (> 239/year: OR 2.79), more efficient fluoroscopy practices (OR 1.72), and lower with moderate

176 X-ray fluoroscopy provides high-resolution, 2-dimensional (2D)

177 Because fluoroscopy provides only limited information about the

178 scopic time, and CT technique (continuous CT fluoroscopy, quick-check method, or a combination of the

179 re was, however, a significant difference in fluoroscopy radiation dose (10.4 Gy . cm(2) +/- 10.6 for

180 However, readily available fluoroscopy remains a limiting factor in its widespread

181 Fluoroscopy remains the mainstay for general identificat

182 166 obtunded patients evaluated with dynamic fluoroscopy required surgery.

183 ned to intracardiac targets by use of an MRI fluoroscopy sequence, and ablated tissue was imaged with

184 Fluoroscopy showed delayed gastric emptying of radiologi

185 guidance, sparing the patient transport to a fluoroscopy suite.

186 bsequent projection of these images over the fluoroscopy system may help in navigation of the mapping

187 e performed in six dogs by using an x-ray/MR fluoroscopy system.

188 tissue definition are disadvantages of x-ray fluoroscopy that could be overcome with the use of MRI.

189 tributed to the use of very-low-frame pulsed fluoroscopy, the avoidance of magnification, and optimal

190 Compared with fluoroscopy, the current imaging standard of care for gu

191 Under real-time MR fluoroscopy, the introducer sheath was tracked toward th

192 th size, thrombolytics, arterial dissection, fluoroscopy time >30 minutes, nonuse of vascular closure

193 An increase in fluoroscopy time ( approximately 1.3 minutes) was noted

194 6+/-36 versus 166+/-46 minutes, P<0.001) and fluoroscopy time (23+/-9 versus 27+/-9 minutes, P=0.023)

195 ignificantly shorter procedural duration and fluoroscopy time (231+/-72 versus 273+/-76 min; P=0.008

196 1.0 vs 20.9 +/- 1.1 minutes, P = 0.001) and fluoroscopy time (9.3 +/- 0.1 vs 11.2 +/- 0.6 vs 11.2 +/

197 Procedure time (PT), fluoroscopy time (FT), contrast volume, and composite ca

198 to VA, 135 [63] vs 160 [77] mL; P = .18) and fluoroscopy time (mean [SD], 26.3 [16.8] vs 32.2 [34.9]

199 , MGT significantly reduced total procedural fluoroscopy time (median [quartiles]) from 31 minutes (2

200 There was no significant difference in fluoroscopy time (P > .50).

201 time was 116+/-43 minutes, the median total fluoroscopy time (skin to skin) was 5.2 (Q1-Q3, 3.0-8.4)

202 Implantation was uncomplicated (mean fluoroscopy time 11.7 minutes), and removal or repositio

203 edure time was 135 (113-170) minutes, median fluoroscopy time 2.8 (1.5-4.4) minutes, and median radia

204 Decreased fluoroscopy time and contrast use were nonlinearly assoc

205 In the overall MATRIX population, fluoroscopy time and DAP were higher with radial compare

206 A dramatic reduction in fluoroscopy time and dose was achieved.

207 and percutaneous intervention, and collected fluoroscopy time and dose-area product (DAP).

208 w levels of radiation exposure: median total fluoroscopy time and effective dose of 6.08 (1.51-12.36)

209 focused on the primary radiation outcomes of fluoroscopy time and kerma-area product, and used meta-r

210 Median fluoroscopy time and median contrast used were also high

211 litates tumor localization, thus reducing CT fluoroscopy time and radiation dose for subsequent RF ab

212 e was used to compare radiation exposure and fluoroscopy time between fluoroscopy units and patient d

213 alysis showed that the overall difference in fluoroscopy time between the two procedures has decrease

214 cases (group 2) of the series were compared: fluoroscopy time decreased from 6.0 (4.1-10.3) minutes i

215 group 1) and last 13 patients (group 2), but fluoroscopy time decreased from 60 +/- 30 to 24 +/- 9 mi

216 Radiation exposure and fluoroscopy time during VCUG were reviewed in 145 childr

217 ted with a small but significant increase in fluoroscopy time for diagnostic coronary angiograms (wei

218 5.2 (Q1-Q3, 3.0-8.4) minutes, and the median fluoroscopy time for left ventricular lead deployment (c

219 The mean CT fluoroscopy time for the RF ablation procedure was 28 se

220 Kerma area product and Fluoroscopy time from 152 684 consecutive CAs and 103 17

221 in 435 (99%) of 439 patients, with a median fluoroscopy time of 7.1 min (range 2.9 to 138.4 min).

222 significant differences between cohorts for fluoroscopy time or contrast use.

223 normalization of operator radiation dose by fluoroscopy time or DAP, the difference remained signifi

224 Procedure time and fluoroscopy time shortened with experience.

225 The median fluoroscopy time was 36 min (range, 14 to 191 min), and

226 ation coefficient was used to assess whether fluoroscopy time was correlated with radiation exposure.

227 Fluoroscopy time was lower in OIC-1 compared with OIC-2

228 o no difference in total procedure time, but fluoroscopy time was significantly reduced in the MN gro

229 In group C, fluoroscopy time was the shortest (median, 4.2 min; P<0.

230 The mean procedure and fluoroscopy time were 177+/-63 minutes and 20+/-8 minute

231 Median procedure and fluoroscopy time were 90 (interquartile range [IQR]: 60

232 to determine whether radiation exposure and fluoroscopy time were dependent on the pig's abdominal g

233 Procedural, left atrial, and fluoroscopy time were reduced by -5%, -11%, and -15% (P<

234 Procedure duration and fluoroscopy time were significantly longer in the pace-c

235 Fluoroscopy time with CS was 49 minutes (IQR, 25-85 minu

236 ure than patients with nonischemic VT (total fluoroscopy time, 2.53 [1.22-11.22] versus 8.51 [5.55-17

237 ment of the guidewire, total procedure time, fluoroscopy time, and amount of contrast for the procedu

238 trends in access site and overall bleeding, fluoroscopy time, and contrast use among 818 facilities

239 for reference air kerma, kerma-area product, fluoroscopy time, and number of images.

240 Procedure duration, fluoroscopy time, and radiofrequency duration were signi

241 based on age, sex, body surface area, total fluoroscopy time, and total acquisition time was used to

242 Primary outcomes of fluoroscopy time, contrast volume, and procedure success

243 al operative metrics (total endovascular and fluoroscopy time, contrast volume, number of angiograms,

244 lysis demonstrated a significant decrease of fluoroscopy time, dose, and procedure time.

245 type and duration of intervention, operator, fluoroscopy time, dose-area product, and air kerma) data

246 nd personnel, total procedure time, total CT fluoroscopy time, mode of CT fluoroscopic guidance (cont

247 to have a positive impact on procedure time, fluoroscopy time, number of lesions, and overall efficac

248 ained highly significant after adjustment on Fluoroscopy time, PCI procedure complexity, change of x-

249 These measures include minimizing fluoroscopy time, the number of images obtained, and dos

250 In recanalization procedures, fluoroscopy time, total procedure time, and mean number

251 Dose-area product, fluoroscopy time, total procedure time, and radiation ex

252 omic mapping failed to decrease procedure or fluoroscopy time.

253 implantation with the potential for reduced fluoroscopy time.

254 /-117 versus 174+/-94 minutes; P=0.0006) and fluoroscopy times (median 20.8 versus 16.6 minutes; P=0.

255 e authors compared computed tomographic (CT) fluoroscopy times and technical success rates between th

256 was used to compare radiation exposures and fluoroscopy times between GCPFL and CFL and to determine

257 th higher success and shorter procedural and fluoroscopy times compared with PVAI in AF with addition

258 The mean fluoroscopy times for endocardial and epicardial mapping

259 ventricular septal re-entry required shorter fluoroscopy times than right atrial re-entry, which enta

260 The mean procedure and fluoroscopy times were 156+/-45 and 50+/-17 minutes for

261 Mean procedural and fluoroscopy times were 96.2+/-21.3 and 19.7+/-6.7 minute

262 ons, presence of junctional tachycardia, and fluoroscopy times were evaluated.

263 The mean procedure, ablation, and fluoroscopy times were longer with VGLB compared with co

264 min vs. 139 +/- 57 min; p < 0.001); however, fluoroscopy times were not different (23 +/- 9 min vs. 2

265 Procedure and fluoroscopy times were similar in both groups (135+/-38

266 le-tailed paired t test for comparison of CT fluoroscopy times, a two-tailed paired t test for compar

267 In the use of fluoroscopy to achieve reproducible alignment of the med

268 dinal studies of knee OA, without the use of fluoroscopy to aid knee positioning.

269 is of tuberculosis have improved from simple fluoroscopy to computerized tomography.

270 A 6-month period of use of CT fluoroscopy to guide abdominal biopsy procedures and cat

271 rough the vertebrobasilar system under C-arm fluoroscopy to occlude the M1 segment of the middle cere

272 m was used in conjunction with or instead of fluoroscopy to position the conventional electrode cathe

273 Limiting CT fluoroscopy to scanning the needle tip rather than scann

274 In this study, we use biplanar high-speed fluoroscopy to track the strain patterns of the turkey l

275 We have developed a method of fluoroscopy to visualize the different types of photorec

276 aluates the feasibility of real-time MRI (MR fluoroscopy) to guide left and right heart catheterizati

277 recurrent, malignant arrhythmia, rather than fluoroscopy, to perform bilateral stellate ganglion bloc

278 Mucus movement was assessed through fluoroscopy tracking of radio-opaque markers.

279 Children were grouped on the basis of the fluoroscopy unit used and their supine anteroposterior a

280 iation exposure and fluoroscopy time between fluoroscopy units and patient diameter groups.

281 enerated automatically by the interventional fluoroscopy units and were recorded at the conclusion of

282 Fluoroscopy used during surgical treatment of nephrolith

283 Coherent anti-Raman spectroscopy, exogenous fluoroscopy using prostate-specific membrane antigen, an

284 tal malignancies normalized to 60 minutes of fluoroscopy was 0.07% for women and 0.1% for men.

285 Chest fluoroscopy was common.

286 esophageal pH electrode also was placed and fluoroscopy was initiated at the onset of a tLESR.

287 edle by using a "quick-check" technique (ie, fluoroscopy was performed sparingly after needle inserti

288 Barium examination with fluoroscopy was used for assessment of the pharynx and e

289 MR fluoroscopy was used for catheter steering.

290 CT fluoroscopy was used to confirm the location of the biop

291 CT fluoroscopy was used to guide TBNA in 12 consecutive pat

292 MR fluoroscopy was used to target and monitor delivery of g

293 cedure and the median procedure time with CT fluoroscopy were 94% less and 32% less, respectively, th

294 radiographs (with knee position confirmed by fluoroscopy) were obtained.

295 ted for infusion by using magnetic resonance fluoroscopy, whereas MRI facilitated monitoring of liver

296 eatography, MR cholangiopancreatography, and fluoroscopy will be demonstrated.

297 ccessible small-bowel loops be visualized at fluoroscopy with representative radiographs to optimize

298 Fluoroscopy with use of contrast material and venography

299 ontradistinction, BaCaps delivery with x-ray fluoroscopy without x-ray/MR imaging (n = 3) resulted in

300 was performed in 7 swine without the use of fluoroscopy, yielding an in vivo accuracy and precision